SALL4 and cholangiocarcinoma: Interestingly, SALL4 expression is elevated in poorly differentiated (3, 20, 21), KRT19+/EpCAM+ aggressive HCCs (19, 22), as well as in combined and mixed HCC–CCA tumors, but is only weakly detected in hepatoblastomas (23).